Analyst
Nephron Research
Equibles does not estimate personal net worth.
Eric Percher is recorded as Analyst at Nephron Research. Eric Percher has spoken on 19 earnings calls and 1 other investor event across 6 companies, most recently for Cardinal Health Inc on August 11, 2026. Those appearances were for Hims & Hers Health, Inc. (HIMS), Cencora, Inc. (COR), Mckesson Corp (MCK), Cardinal Health Inc (CAH), Doximity, Inc. (DOCS) and 1 other company. The companies whose calls Eric Percher spoke on are classified in the Healthcare sector.
“The commentary on opportunities and returns on internal investment was quite clear, and I'd like to ask you to compare the investment priorities for fiscal year 27 relative to where you were as we entered 26, maybe what's continued, continued elevated, or even incremental in 27.”
“The commentary on opportunities and returns on internal investment was quite clear, and I'd like to ask you to compare the investment priorities for fiscal year 27 relative to where you were as we entered 26, maybe what's continued, continued elevated, or even incremental in 27.”
“Kendra, I'd like to follow up on that comment about 3 million subs. I'd be interested to hear your perspective on the recent growth and how much of that maybe a bolus that was waiting versus the ability to maintain it.”
“A question relative to some of the pressures that you faced from price reductions, and I'd like to better understand when you sit across from a manufacturer and you have a discussion, whether it has been AMP or where we are this year with the price reductions, and also as we think about GLP-1 reductions coming…”
Nephron Research
Analyst
Source not stated
Drug Manufacturers - Specialty & Generic · Healthcare
COR
Medical Distribution · Healthcare
MCK
Medical Distribution · Healthcare
DOCS
Health Information Services · Healthcare
AMWL
Health Information Services · Healthcare
